SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-14-197034
Filing Date
2014-05-13
Accepted
2014-05-13 16:12:27
Documents
10
Period of Report
2014-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q d706786d10q.htm 10-Q 490942
2 EX-31.1 d706786dex311.htm EX-31.1 6141
3 EX-31.2 d706786dex312.htm EX-31.2 5872
4 EX-32.1 d706786dex321.htm EX-32.1 5003
  Complete submission text file 0001193125-14-197034.txt   2452914

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT drna-20140331.xml EX-101.INS 197209
6 XBRL TAXONOMY EXTENSION SCHEMA drna-20140331.xsd EX-101.SCH 32576
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE drna-20140331_cal.xml EX-101.CAL 41322
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE drna-20140331_def.xml EX-101.DEF 99601
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE drna-20140331_lab.xml EX-101.LAB 225249
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE drna-20140331_pre.xml EX-101.PRE 164272
Mailing Address 480 ARSENAL ST. BUILDING 1, SUITE 120 WATERTOWN MA 02472
Business Address 480 ARSENAL ST. BUILDING 1, SUITE 120 WATERTOWN MA 02472 617 621 8097
Dicerna Pharmaceuticals Inc (Filer) CIK: 0001399529 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36281 | Film No.: 14837446
SIC: 2834 Pharmaceutical Preparations